Fonte: Clinical and Experimental Medicine. Unidades: IB, FFCLRP, FMRP
Assuntos: ANTINEOPLÁSICOS (ESTUDO IN VITRO), APOPTOSE, NEOPLASIAS DO COLO UTERINO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEZUK, Julia Alejandra et al. Antiproliferative in vitro effects of BI 2536-mediated PLK1 imhibition on cervical adenocarcinoma cells. Clinical and Experimental Medicine, v. 13, n. 1, p. 75-80, 2013Tradução . . Disponível em: https://doi.org/10.1007/s10238-011-0166-1. Acesso em: 02 jun. 2024.APA
Pezuk, J. A., Brassesco, M. S., Oliveira, J. C. de, Morales, A. G., Montaldi, A. P., Sakamoto-Hojo, E. T., et al. (2013). Antiproliferative in vitro effects of BI 2536-mediated PLK1 imhibition on cervical adenocarcinoma cells. Clinical and Experimental Medicine, 13( 1), 75-80. doi:10.1007/s10238-011-0166-1NLM
Pezuk JA, Brassesco MS, Oliveira JC de, Morales AG, Montaldi AP, Sakamoto-Hojo ET, Scrideli CA, Tone LG. Antiproliferative in vitro effects of BI 2536-mediated PLK1 imhibition on cervical adenocarcinoma cells [Internet]. Clinical and Experimental Medicine. 2013 ; 13( 1): 75-80.[citado 2024 jun. 02 ] Available from: https://doi.org/10.1007/s10238-011-0166-1Vancouver
Pezuk JA, Brassesco MS, Oliveira JC de, Morales AG, Montaldi AP, Sakamoto-Hojo ET, Scrideli CA, Tone LG. Antiproliferative in vitro effects of BI 2536-mediated PLK1 imhibition on cervical adenocarcinoma cells [Internet]. Clinical and Experimental Medicine. 2013 ; 13( 1): 75-80.[citado 2024 jun. 02 ] Available from: https://doi.org/10.1007/s10238-011-0166-1
